Pharmaceutical Intermediates Consumption Forecast
Pharmaceutical Intermediates Market: Investments in Manufacturing to Ascend: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029
- Healthcare, Pharmaceuticals and Medical devices
- 2019-04-26
- REP-GB-4515
- 54 Tables
- 185 Figures
- 275 pages
-
Press Release:
Pharmaceutical Intermediates – Increased Care Seeking Rates and The Need for Generics
Incessant rise of chronic ailments vis-à-vis growing elder demographic has grown on the need for generics and branded drugs, prompting pharmaceutical intermediates manufacturers to boost production capacities. The search for care has been increasingly palpable worldwide, fuelling the requirement for generics, APIs and quality drugs, in turn favouring sales of pharmaceutical intermediates.
Market Set to Grow 1.5X between 2019 and 2029
Innovative strategies and work practices of the industry in helping care setting expand their remedial offerings continue to augur well for the pharmaceutical intermediates landscape. While patent expiries remain key development enablers, clinical studies on new therapeutic measures for various ailments are driving advancements in pharmaceutical intermediates.
Stakeholders Vie to Tap Opportune Potential of Emerging Markets
Stakeholders continue to uptake the relatively greater prevalence of chronic ailments and the need for generic drugs and personalized treatment in emerging markets. East Asia continues to lead the pharmaceutical intermediates landscape, with sales growing at a relatively higher rate.
* This data is only a representation. Actual data may vary and will be available in report.
-
2014
-
2018
-
2022
-
2028
The Broader Perspective
Pharmaceutical intermediates manufacturers are taking effective measures to address shortages of generic drugs. In addition, mergers and acquisitions remain a pivotal growth strategy of pharmaceutical intermediates manufacturers, which includes contract manufacturing organizations involved in APIs.
Bulk drug intermediates remain the top-selling variant, with over 60% shares
Customer intermediates sales are expected to grow at a higher rate
Adoption of chemical intermediates is expected to remain relatively low
Generic drug intermediates remain the most lucrative category, accounting for over 70% sales
Gains from branded drug intermediates will remain sluggish, owing to their high cost and complexities in manufacturing
Pharmaceutical intermediates sales in the production of analgesics remain strong, estimated to hold over one-third share
Cardiovascular drugs are also expected account for significant market shares
Sales in production of oral antidiabetic drugs will grow at a promising rate
CMOs/CROs continue to lead the pharmaceutical intermediates landscape, with nearly two-third shares
Biotech & pharma companies also account for notable shares of the market
Demand is expected to remain sluggish in research laboratories
How Growth will Unfold
CMOs/CROs are expected to account for leading shares of the pharmaceutical intermediates market, as these are used as essential ingredients in medicinal chemistry and custom synthesis. Growth rate sales in research laboratories is expected to be similar to those in CMOs/CROs, however revenues will remain sluggish. Demand for pharmaceutical intermediates in biotech & pharma companies will also remain significant.
CMOs/CROs | Research Laboratories | Biotech & pharma companies
* This data is only a representation. Actual data may vary and will be available in report.
Click Here To Know How The Growth Will UnfoldRead in-depth analysis on Pharmaceutical Intermediates Consumption Forecast
Overview
Pharmaceutical Intermediates Market: Global Industry Analysis 2014–2018 and Forecast 2019–2029
A recent market study published by FMI “Pharmaceutical Intermediates Market: Global Industry Analysis 2014–2018 and Forecast 2019–2029” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the pharmaceutical intermediates market, the growth prospects of the market are obtained with maximum precision.
Pharmaceutical Intermediates Market Taxonomy
The global pharmaceutical intermediates market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.
By Product Type
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
By Category
- Branded Drugs
- Generic Drugs
By Application
- Analgesics
- Anti-Infective Drugs
- Cardiovascular Drugs
- Oral Antidiabetic Drugs
- Antimicrobial Drugs
- Others
By End User
- Biotechnology and Pharmaceutical Companies
- Research Laboratories
- Contract Manufacturing Organizations / Contract Research Organizations
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- MEA
What's Included
The report commences with the executive summary of the pharmaceutical intermediates market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the pharmaceutical intermediates market.
Readers can find the detailed taxonomy and the definition of the pharmaceutical intermediates market in this chapter, which will help them understand the basic information about the pharmaceutical intermediates market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of pharmaceutical intermediates market report.
The report provides country wise as well as regional expenditure on health that are expected to impact the market growth significantly during the forecast period.
This section explain the global market value analysis and forecast for the pharmaceutical intermediates market between the forecast periods of 2013-2027 is highlights in this section. This chapter includes the detailed analysis of the historical pharmaceutical intermediates market along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2018 – 2019), and an incremental opportunity for the forecast period (2018 – 2019).
The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.
This chapter explains the key macro-economic factors that are expected to influence the growth of the pharmaceutical intermediates market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the pharmaceutical intermediates market. This chapter also highlights the key market dynamics of the pharmaceutical intermediates market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the pharmaceutical intermediates market.
Based on product type, the pharmaceutical intermediates market is segmented into Chemical Intermediates, Bulk Drug Intermediates and Custom Intermediates. Readers can find information about the key trends and developments in the pharmaceutical intermediates market and market attractiveness analysis based on the product type.
Based on Application the pharmaceutical intermediates market is segmented into Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs and Others. In this chapter, readers can find information about the key trends and developments in the pharmaceutical intermediates market and market attractiveness analysis based on indication.
This chapter provides details about the pharmaceutical intermediates market on the basis of end user, and has been classified into Biotechnology & Pharmaceutical Companies, Research Laboratories, CMOs / CROs. In this chapter, readers can understand the market attractive analysis based on end user.
This chapter explains how the pharmaceutical intermediates market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA)
This chapter includes a detailed analysis of the growth of the North America North America, along with a country-wise assessment that includes the U.S. and Canada.
Readers can find detailed information about several factors, such as the pricing analysis, which are impacting the growth of the Latin America. This chapter also includes the growth prospects of the pharmaceutical intermediates market in the leading LATAM countries such as Brazil, Mexico, and the Rest of Latin America.
Important growth prospects of the pharmaceutical intermediates market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand, Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia pharmaceutical intermediates market in this chapter. Readers can find detailed information about the growth parameters of the South Asia pharmaceutical intermediates market during the period 2019–2029.
This chapter highlights the growth of the pharmaceutical intermediates market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the pharmaceutical intermediates market in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania pharmaceutical intermediates market.
This chapter provides information about how the pharmaceutical intermediates market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029.
In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the pharmaceutical intermediates market along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the pharmaceutical intermediates market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhetech, BASF SE, Vertellus Holdings LLC, Sanofi S.A., A. R. Life Sciences Private Limited, Dishman Group, Chemcon Speciality Chemicals Pvt. Ltd, Dextra Laboratories Ltd, Dextra Laboratories Ltd, Eastar Industries, Pfizer Inc., Bristol-Myers Squibb Company, Arkema Group, Interchem and Cambrex Corporation
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the pharmaceutical intermediates market report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the pharmaceutical intermediates market.
How the research was conducted?
Primary Research
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Drug Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Distributors
- Pharmacists / Pharmacy Benefit Managers
- Hospital Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Disease Patterns, Treatment and Prescription Patterns
- Regulatory and Reimbursement Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, Installed Base, Replacement Cycles, Refurbishment
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
Secondary Research
- Industry Magazines
- Factiva
- Company Press Releases
- Annual Reports and Investor Presentations
- Active Pharmaceutical Ingredients Committee
- Indian Drug Manufacturers' Association
- Government of Canada
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
World Bank, WHO, IMF, OECD
Primary Interview Splits
Pharmaceutical Intermediates Market Reports - Table of Contents
22. Assumptions and Acronyms Used
23. Research Methodology
List Of Figures
Figure 01: Global Pharmaceutical Intermediates Market Share, By Product Type (2018)
Figure 02: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 03: Global Pharmaceutical Intermediates Market Share, By Category (2018)
Figure 04: Global Pharmaceutical Intermediates Market Share, By Application (2018)
Figure 05: Global Pharmaceutical Intermediates Market Share, By End User (2018)
Figure 06: Global Pharmaceutical Intermediates Market Share, By Region (2018)
Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 08: Global Pharmaceutical Intermediates Historical Market Size and Y-o-Y, 2014-2018
Figure 09: Global Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 10: Global Pharmaceutical Intermediates Market Absolute $ Opportunity, 2013–2028
Figure 11: : Global Pharmaceutical Intermediates Market Analysis by Product Type –2019 & 2029
Figure 12: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Figure 13: : Global Pharmaceutical Intermediates Market Analysis by Category –2019 & 2029
Figure 14: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 15: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Figure 16: : Global Pharmaceutical Intermediates Market Analysis by Application –2019 & 2029
Figure 17: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 18: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Figure 19: : Global Pharmaceutical Intermediates Market Analysis by End User –2019 & 2029
Figure 20: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 21: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Figure 22: : Global Pharmaceutical Intermediates Market Analysis by Region –2019 & 2029
Figure 23: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Region, 2019 – 2029
Figure 24: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Figure 25: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 26: North America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 27: : North America Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 28: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 29: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 30: : North America Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 31: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 32: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 33: : North America Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 34: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 35: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 36: : North America Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 37: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 38: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 39: : North America Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 40: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 41: North America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 42: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 43: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 44: : Latin America Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 45: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 46: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 47: : Latin America Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 48: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 49: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 50: : Latin America Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 51: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 52: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 53: : Latin America Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 54: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 55: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 56: : Latin America Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 57: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 58: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 59: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 60: Europe Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 61: : Europe Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 62: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 63: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 64: : Europe Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 65: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 66: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 67: : Europe Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 68: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 69: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 70: : Europe Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 71: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 72: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 73: : Europe Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 74: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 75: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 76: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 77: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 78: : South Asia Pharmaceutical Intermediates Market Analysis by Country – 2019 & 2029
Figure 79: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 80: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 81: : South Asia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 82: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 83: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 84: : South Asia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 85: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 86: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 87: : South Asia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 88: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 89: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 90: : South Asia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 91: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 92: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 93: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 94: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 95: : East Asia Pharmaceutical Intermediates Market Analysis by Country–2019 & 2029
Figure 96: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 97: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 98: : East Asia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 99: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 100: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 101: : East Asia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 102: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 103: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 104: : East Asia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 105: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 106: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 107: : East Asia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 108: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 109: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 110: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 111: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 112: : Oceania Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 113: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 114: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 115: : Oceania Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 116: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 117: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 118: : Oceania Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 119: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 120: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 121: : Oceania Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 122: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 123: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 124: : Oceania Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 125: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 126: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 127: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 128: MEA Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 129: : MEA Pharmaceutical Intermediates Market Analysis by Country – 2019 & 2029
Figure 130: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 131: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 132: : MEA Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 133: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 134: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 135: : MEA Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 136: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 137: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 138: : MEA Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 139: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 140: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 141: : MEA Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 142: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 143: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 144: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 145: China Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 146: : China Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 147: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 148: China Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 149: : China Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 150: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 151: China Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 152: : China Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 153: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 154: China Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 155: : China Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 156: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 157: China Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 158: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 159: India Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 160: : India Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 161: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 162: India Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 163: : India Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 164: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 165: India Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 166: : India Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 167: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 168: India Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 169: : India Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 170: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 171: India Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 172: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 173: Russia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 174: : Russia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 175: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 176: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 177: : Russia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 178: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 179: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 180: : Russia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 181: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 182: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 183: : Russia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 184: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 185: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
List Of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 04: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 05: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 06: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 07: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Table 08: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 09: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 10: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 11: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 12: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 13: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 14: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 15: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 16: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 17: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 18: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 19: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 20: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 21: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 22: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 23: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 24: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 25: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 26: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 27: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 28: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 29: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 30: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 31: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 32: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 33: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 34: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 35: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 36: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 37: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 38: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 39: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 40: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 41: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 42: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 43: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 44: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 45: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 46: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 47: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 48: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 49: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 50: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 51: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 52: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 53: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 54: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
To Learn More About our Comprehensive Perspective on Pharmaceutical Intermediates Consumption Forecast, Contact Us
Get in touch
Harish Tiwari
Global Head - Business Development
Pranay Mhaisekar
Client Partner - Global Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.